Joint Filing AgreementJoint Filing Agreement • November 29th, 2018 • 683 Capital Management, LLC • Pharmaceutical preparations
Contract Type FiledNovember 29th, 2018 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G dated November 29, 2018 (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Syndax Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.